ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

NCT07420959 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
38
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mayo Clinic